What is the Delirium Market Size?
According to 6Wresearch internal database and industry insights,
Global Delirium market was valued at
USD 1.5 billion in 2024 and is anticipated to exceed
USD 2.4 billion by 2031, registering a steady at a
CAGR of 6.20% during the forecast period.
This market is experiencing significant growth due to the rising prevalence of delirium in elderly and ICU patients, as well as increasing awareness of neuropsychiatric disorders. Growing hospitalization rates, the expansion of geriatric care infrastructure, and an increasing number of surgical procedures are also fueling demand. Moreover, advancements in diagnostic tools and treatment approaches, alongside higher healthcare expenditure in emerging economies, are contributing to the overall market expansion.
Major Growth Factors of the Delirium Market
- Rising geriatric population prone to cognitive disorders
- Increased ICU admissions and postoperative complications
- Growing awareness of early detection and intervention
- Expansion of neuropsychiatric research
- Technological advances in brain monitoring and diagnostics
- Higher healthcare spending in emerging regions
- Development of pharmacological and non-pharmacological therapies
- Government initiatives for mental health awareness
Delirium Market Trends
The delirium market is witnessing a growing focus on early diagnosis and intervention through cognitive screening tools and monitoring systems. There is an increasing trend toward multidisciplinary care approaches involving neurologists, psychiatrists, and geriatricians. Digital therapeutics, AI-based detection models, and wearable monitoring systems are also being explored to improve patient outcomes and reduce hospital stays.
Emerging Developments in the Delirium Market
The delirium market is emerging through the development of targeted treatment protocols, integration of AI in cognitive assessment, and partnerships between hospitals and tech companies to create advanced monitoring platforms. Research on biomarkers and genetic predispositions is opening new pathways for personalized delirium management. Furthermore, global health organizations are pushing for guidelines to standardize delirium care in clinical settings.
Major Companies in the Delirium Market
- Pfizer Inc.
- Novartis AG
- Merck & Co., Inc.
- Johnson & Johnson
- GlaxoSmithKline plc
- Eli Lilly and Company
- AbbVie Inc.
- Teva Pharmaceutical Industries Ltd.
How big is the delirium market : FAQs
The delirium market was valued at approximately USD 1.5 billion in 2025 and is projected to reach around USD 2.4 billion by 2031.
The delirium market is anticipated to grow at a CAGR of 6.20% during the forecast period.
Key trends include AI-driven diagnostics, early screening tools, multidisciplinary treatment approaches, and increased use of digital therapeutics.
The delirium market is driven by the rising elderly population, ICU-related complications, growing awareness of cognitive disorders, and advancements in treatment.
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on
sales@6wresearch.com